On 10 March 2014, CureVac has won a $2 million prize awarded by the European Commission to stimulate new vaccine technologies that might help the developing world, because the company's research could lead to a new generation of vaccines that don't need refrigeration.
March 2014, CureVac has won a $2 million prize awarded by the European Commission to stimulate new vaccine technologies. This was on 10. This $2 million prize awarded by the European Commission to stimulate new vaccine technologies might help the developing world. The company's research could lead to a new generation of vaccines. These vaccines don't need refrigeration.